Lack of association with PEDF Met72Thr variant in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in a Han Chinese population

Current Eye Research

Volumn 37, Issue 1, 2012, Pages 68-72

  Wu, Kunfang ^a   Wen, Feng ^a   Zuo, Chengguo ^a   Li, Meng ^a   Zhang, Xiongze ^a   Chen, Hui ^a   Zeng, Renpan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Han Chinese population; Neovascular age related macular degeneration; Pigment epithelium derived factor; Polymorphisms; Polypoidal choroidal vasculopathy

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR;

ADULT; AGED; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; EXUDATIVE MACULAR DEGENERATION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CHINA; CHOROID; CHOROID DISEASES; DNA; EYE PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; POLYMORPHISM, GENETIC; POLYPLOIDY; PREVALENCE; SERPINS;

EID: 83655165154     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.618289     Document Type: Article

References (42)

1. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: The Rotterdam Study. Arch Ophthalmol. 1998;116:653-658. (Pubitemid 28414581)
2. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol. 1988;32:375-413.
3. de Jong PT. Age-related macular degeneration. N Engl J Med. 2006;355:1474-1485. (Pubitemid 44511562)
4. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina (Philadelphia, Pa). 1990;10:1-8. (Pubitemid 20201879)
5. Wen F, Chen C, Wu D, Li H. Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol. 2004;242:625-629. (Pubitemid 39242836)
6. Liu Y, Wen F, Huang S et al. Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol. 2007;245:1441-1445. (Pubitemid 47423325)
7. Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol. 2007;144:15-22.
8. Byeon SH, Lee SC, Oh HS, Kim SS, Koh HJ, Kwon OW. Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol. 2008;52:57-62. (Pubitemid 351462228)
9. Yannuzzi LA, Wong DW, Sforzolini BS et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol. 1999;117:1503-1510. (Pubitemid 29536478)
10. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 1995;333:1757-1763.
11. Amin R, Puklin JE, Frank RN. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci. 1994;35: 3178-3188. (Pubitemid 24241356)
12. Kvanta A, Algvere PV, Berglin L, Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1996;37:1929-1934. (Pubitemid 26324159)
13. Ishibashi T, Hata Y, Yoshikawa H, Nakagawa K, Sueishi K, Inomata H. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol. 1997;235:159-167. (Pubitemid 27129479)
14. Dawson DW, Volpert OV, Gillis P et al. Pigment epitheliumderived factor: A potent inhibitor of angiogenesis. Science. 1999;285:245-248. (Pubitemid 29329995)
15. Martin G, Schlunck G, Hansen LL, Agostini HT. Differential expression of angioregulatory factors in normal and CNVderived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol. 2004;242:321-326. (Pubitemid 38647606)
16. Tombran-Tink J, Chader GG, Johnson LV. PEDF: A pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res. 1991;53:411-414.
17. Wu YQ, Notario V, Chader GJ, Becerra SP. Identification of pigment epithelium-derived factor in the interphotoreceptor matrix of bovine eyes. Protein Expr Purif. 1995;6: 447-456.
18. Wu YQ, Becerra SP. Proteolytic activity directed toward pigment epithelium-derived factor in vitreous of bovine eyes. Implications of proteolytic processing. Invest Ophthalmol Vis Sci. 1996;37:1984-1993. (Pubitemid 26321691)
19. Ogata N, Matsuoka M, Imaizumi M, Arichi M, Matsumura M. Decrease of pigment epithelium-derived factor in aqueous humor with increasing age. Am J Ophthalmol. 2004;137:935-936. (Pubitemid 38582050)
20. Duh EJ, Yang HS, Suzuma I et al. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci. 2002;43:821-829. (Pubitemid 34184503)
21. Liu H, Ren JG, Cooper WL, Hawkins CE, Cowan MR, Tong PY. Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci USA. 2004;101:6605-6610. (Pubitemid 38586021)
22. Holekamp NM, Bouck N, Volpert O. Pigment epitheliumderived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol. 2002;134:220-227. (Pubitemid 34831826)
23. Mori K, Duh E, Gehlbach P et al. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol. 2001;188:253-263. (Pubitemid 32622916)
24. Mori K, Gehlbach P, Yamamoto S et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci. 2002;43:1994-2000. (Pubitemid 34587052)
25. Gehlbach P, Demetriades AM, Yamamoto S et al. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Ther. 2003;10:637-646. (Pubitemid 36553609)
26. Saishin Y, Silva RL, Saishin Y et al. Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye. Hum Gene Ther. 2005;16:473-478. (Pubitemid 40647144)
27. Zhou XY, Liao Q, Pu YM et al. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization. Chin Med J. 2009;122:2711-2717.
28. Lin JM, Wan L, Tsai YY et al. Pigment epithelium-derived factor gene Met72Thr polymorphism is associated with increased risk of wet age-related macular degeneration. Am J Ophthalmol. 2008;145:716-721.
29. Mattes D, Haas A, Renner W et al. Analysis of three pigment epithelium-derived factor gene polymorphisms in patients with exudative age-related macular degeneration. Mol Vis. 2009;15:343-348.
30. Qu Y, Zhang X, Dai H et al. Pigment epithelium-derived factor gene polymorphisms in exudative age-related degeneration in a chinese cohort. Curr Eye Res. 2011;36:60-65.
31. Bessho H, Kondo N, Honda S, Kuno S, Negi A. Coding variant Met72Thr in the PEDF gene and risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Mol Vis. 2009;15:1107-1114.
32. Kondo N, Honda S, Ishibashi K, Tsukahara Y, Negi A. Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2008;49:1101-1105.
33. Li M, Wen F, Zuo C et al. SERPING1 polymorphisms in polypoidal choroidal vasculopathy. Mol Vis. 2010;16:231-239.
34. Iida T. [Diagnostic criteria for polypoidal choroidal vasculopathy and their clinical significance]. Nippon Ganka Gakkai Zasshi. 2005;109:383-384.
35. Purcell S, Neale B, Todd-Brown K et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575. (Pubitemid 47330214)
36. Faul F, Erdfelder E, Lang AG, Buchner A. G Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175-191.
37. Bhutto IA, McLeod DS, Hasegawa T et al. Pigment epithelium- derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with agerelated macular degeneration. Exp Eye Res. 2006;82:99-110. (Pubitemid 43063401)
38. Kaur I, Hussain A, Hussain N et al. Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47:3729-3735. (Pubitemid 46044283)
39. Lin JM, Wan L, Tsai YY et al. HTRA1 polymorphism in dry and wet age-related macular degeneration. Retina (Philadelphia, Pa). 2008;28:309-313. (Pubitemid 351643162)
40. Yamagishi S, Amano S, Inagaki Y et al. Pigment epithelium- derived factor Met72Thr polymorphism in patients with diabetic microangiopathy. Int J Clin Pharmacol Res. 2002;22:67-71. (Pubitemid 36758532)
41. Lin JM, Wan L, Tsai YY et al. Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Am J Ophthalmol. 2008;145:1045-1051.
42. Qu Y, Dai H, Zhou F et al. Vascular endothelial growth factor gene polymorphisms and risk of neovascular age-related macular degeneration in a Chinese cohort. Ophthalmic Res. 2011;45:142-148.